Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity (MACRONUTR)
This study is ongoing, but not recruiting participants.
First Received: August 30, 2007   Last Updated: June 4, 2008   History of Changes
Sponsored by: University of Lausanne
Information provided by: University of Lausanne
ClinicalTrials.gov Identifier: NCT00523562
  Purpose

The purpose of this study is to assess how the macronutrient composition of the diet effects

  • lipid and glucose metabolism
  • intrahepatic lipids
  • insulin sensitivity

in healthy lean subjects and in subjects with a high metabolic risk (ie overweight and offsprings of patients with type 2 diabetes mellitus).


Condition Intervention
Metabolic Syndrome X
Liver Diseases
Other: changes in energy and macronutrient intake

MedlinePlus related topics: Diets Liver Diseases Metabolic Syndrome
Drug Information available for: Insulin Lipids
U.S. FDA Resources
Study Type: Interventional
Study Design: Basic Science, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: Study of the Role of Insulin Resistance in the Pathogenesis of the Metabolic Syndrome and of Non-Alcoholic Steatohepatitis

Further study details as provided by University of Lausanne:

Primary Outcome Measures:
  • plasma triglycerides and free fatty acids [ Time Frame: 6 days ] [ Designated as safety issue: No ]
  • intra-hepatic lipids [ Time Frame: 6 days ] [ Designated as safety issue: No ]
  • insulin sensitivity [ Time Frame: 6 days ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • lipid oxidation [ Time Frame: 6 days ] [ Designated as safety issue: No ]
  • plasma beta-hydroxybutyrate [ Time Frame: 6 days ] [ Designated as safety issue: No ]
  • gene expression in skeletal muscle and adipose tissue [ Time Frame: 6 days ] [ Designated as safety issue: No ]

Estimated Enrollment: 60
Study Start Date: July 2006
Estimated Study Completion Date: January 2009
Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: changes in energy and macronutrient intake
    hypercaloric diet fructose supplementation fat supplementation protein supplementation
Detailed Description:

The study is aimed at assessing the effects of changes in total energy, sugars, lipids, and protein intake on intrahepatic lipids, plasma lipids, and hepatic and whole body insulin resistance in

  • lean men and women with no family history of diabetes
  • overweight men and women
  • lean men with a family history of type 2 diabetes

Subjects are studied after a 6-day period of

  • isocaloric diet with 100% calorie requirement, of which 55% carbohydrate, 15% protein, and 30% fat)
  • the same isocaloric diet supplemented with 3g/kg body weight/day fructose
  • hypercaloric high fat diet with 130% energy requirement, of which 55% carbohydrate, 15% protein, 60% fat
  • hypercaloric high fat+protein diet with 145% energy requirement, of which 55% carbohydrate, 30% protein, 60% fat

Measurements performed after 6 days on each diet include

  • intrahepatic and intramyocellular lipids (1H-MRS)
  • hepatic and whole body insulin sensitivity (hyperinsulinemic-euglycemic clamp)
  • body weight
  • plasma concentrations of hormones and substrates
  • gene expression profile in skeletal muscle (vastus lateralis) and adipose tissue (subcutaneous abdominal)
  Eligibility

Ages Eligible for Study:   18 Years to 40 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Males and females
  • Age 18-40
  • Informed consent obtained
  • Subgroup with overweight (body mass index [BMI] > 25)
  • Subgroup with family history of type 2 diabetes mellitus

Exclusion Criteria:

  • Smokers
  • Alcohol intake > 30g/day
  • Drug abuse
  • Diabetes mellitus
  • Any concurrent medication
  • Having a pacemaker
  • History of orthopedic surgery
  • History of metal foreign bodies
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00523562

Locations
Switzerland
Centre Hospitalier Universitaire Vaudois
Lausanne, Switzerland, CH-1011
Sponsors and Collaborators
University of Lausanne
Investigators
Principal Investigator: Luc Tappy, MD University of Lausanne
  More Information

No publications provided

Responsible Party: Department of Physiology, University of Lausanne ( Prof. L uc Tappy )
Study ID Numbers: protocol 140/04/CE/FBM
Study First Received: August 30, 2007
Last Updated: June 4, 2008
ClinicalTrials.gov Identifier: NCT00523562     History of Changes
Health Authority: Switzerland: Ethikkommission

Keywords provided by University of Lausanne:
fructose
dietary lipids
dietary proteins
hepatic steatosis
insulin resistance
Healthy humans
overweight humans
obese humans

Study placed in the following topic categories:
Obesity
Liver Diseases
Metabolic Syndrome X
Metabolic Diseases
Fatty Liver
Overweight
Healthy
Insulin
Abdominal Obesity Metabolic Syndrome
Hyperinsulinism
Digestive System Diseases
Insulin Resistance
Glucose Metabolism Disorders
Metabolic Disorder

Additional relevant MeSH terms:
Hyperinsulinism
Liver Diseases
Pathologic Processes
Disease
Digestive System Diseases
Metabolic Diseases
Metabolic Syndrome X
Syndrome
Insulin Resistance
Glucose Metabolism Disorders

ClinicalTrials.gov processed this record on May 07, 2009